4 March 2024
Braveheart Investment Group Plc
("Braveheart", the "Company" or the "Group")
Completion of sale of Phasefocus
Braveheart Investment Group (AIM: BRH), is pleased to announce that, further to the announcement on 22 December 2023 regarding the sale of Phasefocus Holdings Limited ("Phasefocus") to Bruker UK Limited, all outstanding conditions to the sale have now been satisfied and the sale has therefore completed. The total proceeds receivable by the Company for the Sale was approximately £2.1 million (after expenses).
Trevor Brown, CEO of Braveheart, commented: "The sale of our holding in Phasefocus represents a gain of £1.31m over cost, which is a highly satisfactory CAGR of 48.29% for Braveheart shareholders."
For further information:
| Braveheart Investment Group plc | Tel: 01738 587555 |
| Trevor Brown, Chief Executive Officer Viv Hallam, Executive Director | |
| Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: 020 3328 5656 |
| James Reeve / George Payne | |
| | |
| Peterhouse Capital Limited (Joint Broker) | Tel: 020 7469 0936 |
| Duncan Vasey / Lucy Williams
| |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
